| dc.contributor.author | Porter, Ross John | |
| dc.contributor.author | Andrews, Caroline | |
| dc.contributor.author | Brice, Daniel Paul | |
| dc.contributor.author | Durum, Scott Kenneth | |
| dc.contributor.author | McLean, Mairi Hall | |
| dc.date.accessioned | 2019-07-17T23:04:06Z | |
| dc.date.available | 2019-07-17T23:04:06Z | |
| dc.date.issued | 2018-09-15 | |
| dc.identifier.citation | Porter , R J , Andrews , C , Brice , D P , Durum , S K & McLean , M H 2018 , ' Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? ' , Inflammatory Bowel Diseases , vol. 24 , no. 10 , pp. 2123-2134 . https://doi.org/10.1093/ibd/izy230 | en |
| dc.identifier.issn | 1078-0998 | |
| dc.identifier.other | PURE: 125122905 | |
| dc.identifier.other | PURE UUID: 75128111-a520-40ea-bc65-906f8cfab7ad | |
| dc.identifier.other | Scopus: 85056844442 | |
| dc.identifier.other | ORCID: /0000-0002-7443-2653/work/94084011 | |
| dc.identifier.uri | http://hdl.handle.net/2164/12590 | |
| dc.description | Drs. Andrews and Durum are supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, National Institutes of Health, USA. | en |
| dc.format.extent | 12 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Inflammatory Bowel Diseases | en |
| dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in Inflammatory Bowel Disease following peer review. The version of recordRoss John Porter, Caroline Andrews, Daniel Paul Brice, Scott Kenneth Durum, Mairi Hall McLean; Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?, Inflammatory Bowel Diseases, Volume 24, Issue 10, 15 September 2018, Pages 2123–2134., is available online at: https://academic.oup.com/ibdjournal/article/24/10/2123/5055343 | en |
| dc.subject | Inflammatory Bowel Disease | en |
| dc.subject | immunoregulation | en |
| dc.subject | cytokine | en |
| dc.subject | ulcerative colitis | en |
| dc.subject | Crohn's disease | en |
| dc.subject | treatment | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? | en |
| dc.type | Journal item | en |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Postprint | en |
| dc.identifier.doi | https://doi.org/10.1093/ibd/izy230 | |
| dc.date.embargoedUntil | 2019-07-18 | |
| dc.identifier.vol | 24 | en |
| dc.identifier.iss | 10 | en |
